Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Voice of the Consumer: Consumer Health 2024
... and generic OTCs, the rise of holistic health, and the evolution of the vitamins and dietary supplements space. Euromonitor International’s Voice of the Consumer: Consumer Health 2024 global briefing examines the size, growth trends and ... Read More
-
Alopecia - Global Clinical Trials Review, 2025
... the clinical trials on Alopecia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Drugs and Medicaments - International Trade in Q4-2024: Top Markets' Performance by Major Competitors
... Drugs and Medicaments recorded a year-over-year increase of +11.2% in $. As regards major competitors of Drugs and Medicaments, in year 2024 Ireland and Italy showed the best results in USD values compared to the ... Read More
-
Diabetic Nephropathy - Global Clinical Trials Review, 2025
... data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Myelodysplastic Syndrome - Global Clinical Trials Review, 2025
... data relating to the clinical trials on Myelodysplastic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Friedreich Ataxia - Global Clinical Trials Review, 2025
... data relating to the clinical trials on Friedreich Ataxia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Global Clinical Trials Review, 2025
... Purpura (Immune Thrombocytopenic Purpura Clinical trials scenario. This report provides top line data relating to the clinical trials on Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura. Report includes an overview of trial numbers and their average ... Read More
-
Polycystic Kidney Disease - Global Clinical Trials Review, 2025
... provides top line data relating to the clinical trials on Polycystic Kidney Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
... products from the developing countries is mainly responsible for the growth of poultry medicine/pharmaceuticals market as it results in increased poultry farming practices. The rise in illnesses in poultry, especially Newcastle disease and Coccidiosis, leads ... Read More
-
Osteoporosis_Global Clinical Trials Review, 2025
... trials on Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), ... Read More
-
Ewing Sarcoma - Global Clinical Trials Review, 2025
... data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Cannabis in South Africa
... of cannabis in private spaces. In turn, the change in the legislative environment significantly increased social acceptance, which drove consumption and cultivation rates across the country. Euromonitor International's Cannabis in South Africa market report offers ... Read More
-
U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030
... an estimated value of USD 883.97 billion by 2030. This growth can be attributed to the rising prevalence of chronic diseases, increasing geriatric population, growing healthcare expenditure by government organizations, and extensive efforts to improve ... Read More
-
Obesity: 68-Market Analysis and Sales Forecast
... were $12.3 billion in 2021, growing to $206.5 billion in 2031. The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 85% and 84% of 68-market sales in 2021 and 2031, ... Read More
-
Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031
... for the obesity market through 2031. GlobalData estimates sales of obesity therapeutics to be approximately $10.5 billion across the 7MM in 2021. By 2031, GlobalData expects the obesity market to grow at a strong compound ... Read More
-
Cannabis in the US
... I to Schedule III, which could attract more investment and improve banking access for cannabis businesses. Euromonitor International's Cannabis in USA market report offers a comprehensive guide to the size and shape of this emerging ... Read More
-
Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029
... like oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is a major growth driver. Moreover, improved bioinformatics tools for data analysis and interpretation are enhancing the usability of NGS, driving its widespread adoption. “The ... Read More
-
Medical Cannabis in Australia - Industry Market Research Report
... report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (TB, HAI, STD), Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx (RT-PCR, INAAT)), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2029
... that will fuel POC testing is the favourable government initiatives and funding. Globally, governments consider these technologies essential in improving the accessibility of health care, bringing down costs, and enhancing outcomes for patients. Many governments ... Read More
-
Dermatologists
... in group practices or as solo practitioners; some work for hospitals, medical schools, or outpatient facilities. COMPETITIVE LANDSCAPE Demand for dermatologists is driven by demographics and population growth. The profitability of dermatology practices depends on ... Read More
-
Pharmaceutical Manufacturing
... US), as well as AstraZeneca and GlaxoSmithKline (both based in the UK), Bayer (Germany), Novartis and Roche (both based in Switzerland), and Sanofi (France). COMPETITIVE LANDSCAPE Pharmaceutical manufacturers compete to discover and commercialize ever-more effective ... Read More
-
Pediatric Vaccine Global Market Opportunities And Strategies To 2033
... Pneumococcal Disease; Influenza; Measles, Mumps And RubellaCovering: Merck & Co.Inc.; SANOFI S.A.; Pfizer, Inc.; Seqirus (CSL Limited); GlaxoSmithKline plc. Pediatric Vaccine Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the ... Read More
-
Global Autogenous Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... 2024 and is forecast to a readjusted size of USD 625 million by 2031 with a CAGR of 4.3% during review period. Autogenous vaccines, also called autologous vaccines, autovaccines, “self” or custom vaccines, are vaccines, ... Read More
-
Influenza Vaccines Global Market Opportunities And Strategies To 2033
... And Institutional Supply5) By Age Group: Pediatric; AdultCovering: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc Influenza Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company ... Read More
-
Lyophilized Injectable Drugs Global Market Opportunities And Strategies To 2033
... By Indication: Oncology; Infectious Diseases; Autoimmune Diseases; Metabolic Conditions4) By End-User: Hospitals; Ambulatory Surgery Centers (ASCs); Specialty ClinicsCovering: Novartis AG; Pfizer Inc.; Sanofi SA; Baxter International Inc.; Hikma Pharmaceuticals plc Lyophilized Injectable Drugs Global Market ... Read More
Research Assistance
